Free Trial

Kenvue (KVUE) Stock Forecast & Price Target

Kenvue logo
$17.50 -0.20 (-1.10%)
As of 09:42 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Kenvue - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
10
Buy
0

Based on 10 Wall Street analysts who have issued ratings for Kenvue in the last 12 months, the stock has a consensus rating of "Hold." Out of the 10 analysts, 10 have given a hold rating for KVUE.

Consensus Price Target

$18.43
5.28% Upside
According to the 10 analysts' twelve-month price targets for Kenvue, the average price target is $18.43. The highest price target for KVUE is $19.00, while the lowest price target for KVUE is $18.00. The average price target represents a forecasted upside of 5.28% from the current price of $17.51.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for KVUE and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Kenvue and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KVUE Analyst Ratings Over Time

TypeCurrent Forecast
10/12/25 to 10/12/26
1 Month Ago
9/12/25 to 9/12/26
3 Months Ago
7/14/25 to 7/14/26
1 Year Ago
10/12/24 to 10/12/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
5 Buy rating(s)
Hold
10 Hold rating(s)
12 Hold rating(s)
13 Hold rating(s)
8 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$18.43$19.27$19.33$20.92
Forecasted Upside5.28% Upside8.67% Upside3.06% Upside25.44% Upside
Consensus RatingHoldHoldHoldHold

KVUE Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

KVUE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Kenvue Stock vs. The Competition

TypeKenvueConsumer Staples CompaniesBroader Market
Consensus Rating Score
2.00
2.22
2.53
Consensus RatingHoldHoldModerate Buy
Predicted Upside4.38% Upside166.83% Upside19.60% Upside
News Sentiment Rating
Neutral News

See Recent KVUE News
Positive News
Positive News
Report Date
0 Results
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/11/2026
Weiss Ratings logo
Weiss Ratings
3 of 5 stars
 Reiterated RatingHold (C)
8/11/2026
UBS Group AG logo
UBS Group
4 of 5 stars
Peter Grom
2 of 5 stars
Lower TargetNeutral$20.00 ➝ $19.00+0.18%
7/21/2026
Barclays PLC logo
Barclays
3 of 5 stars
Lauren Lieberman
Lauren Lieberman
2 of 5 stars
Boost TargetEqual Weight$18.00 ➝ $19.00+0.03%
7/7/2026 DowngradeStrong-Buy ➝ Hold
4/15/2026Lower TargetNeutral$20.00 ➝ $19.00+9.79%
3/6/2026 UpgradeHold
2/18/2026Boost TargetHold$17.00 ➝ $18.00-3.92%
1/30/2026DowngradeBuy ➝ Hold$23.00 ➝ $18.00+4.74%
11/3/2025 DowngradeStrong-Buy ➝ Hold
10/28/2025Set Target$18.00+24.27%
10/28/2025 Reiterated RatingNeutral
10/24/2025 Set Target$18.00+19.32%
10/10/2025Lower TargetOverweight$24.00 ➝ $21.00+24.15%
10/8/2025Lower TargetBuy$25.00 ➝ $21.00+30.39%
10/2/2025Lower TargetNeutral$22.00 ➝ $19.00+20.52%
9/26/2025Set Target$22.00+35.79%
8/8/2025Lower TargetSector Perform$24.00 ➝ $22.00+3.17%
2/24/2025Boost TargetOverweight$24.00 ➝ $27.00+15.85%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 09:42 AM ET.


Should I Buy Kenvue Stock? KVUE Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, October 7, 2026. Please send any questions or comments about these Kenvue pros and cons to contact@marketbeat.com.

Kenvue
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Kenvue Inc.:

  • The stock is currently trading at $17.54, which is significantly below the consensus price target of $19.00 set by twelve research firms, suggesting potential upside for investors who believe the market is undervaluing the company's fundamentals.
  • Kenvue Inc. offers a high dividend yield of 4.78%, providing a substantial income stream for investors, as the company recently paid a quarterly dividend of $0.21 per share to shareholders of record on September 21st.
  • The company demonstrated strong financial performance in its most recent quarter, reporting revenue of $3.96 billion, which was up 3.0% compared to the same quarter last year, indicating steady growth in its consumer health product lines.
  • With a beta of 0.48, Kenvue Inc. exhibits lower volatility than the broader market, making it a potentially stable defensive holding for investors seeking to reduce portfolio risk during periods of market uncertainty.
  • Institutional investors continue to show confidence in the stock, with 97.64% of the company's shares owned by institutional investors and hedge funds, including recent new positions acquired by funds like Andra AP fonden and HBK Investments L P.

Kenvue
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Kenvue Inc. for these reasons:

  • The company has a high dividend payout ratio of 96.55%, meaning it is distributing nearly all of its earnings as dividends, which may limit its ability to reinvest in growth or absorb financial shocks without cutting the dividend.
  • Recent analyst sentiment has turned cautious, with several firms downgrading their ratings, such as Zacks Research lowering its rating from "strong-buy" to "hold" and Wall Street Zen downgrading from "buy" to "hold" in recent months.
  • Kenvue Inc. missed its earnings expectations in its latest quarterly report, posting an EPS of $0.31 compared to the consensus estimate of $0.32, which may signal challenges in maintaining profitability or meeting investor expectations.
  • The stock is trading near its 52-week low of $14.02, having fallen from a high of $20.13, indicating a significant decline in value over the past year that may reflect broader market concerns or company-specific issues.
  • Short interest has been a notable factor, with 57,631,922 shares shorted as of the most recent record date, representing a short percentage of float of 3.05%, which suggests a portion of the market is betting against the stock's performance.

KVUE Forecast - Frequently Asked Questions

According to the research reports of 10 Wall Street equities research analysts, the average twelve-month stock price forecast for Kenvue is $18.43, with a high forecast of $19.00 and a low forecast of $18.00.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Kenvue in the last year. There are currently 10 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" KVUE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KVUE, but not buy additional shares or sell existing shares.

According to analysts, Kenvue's stock has a predicted upside of 5.28% based on their 12-month stock forecasts.

Kenvue has been rated by research analysts at Barclays, UBS Group, and Weiss Ratings in the past 90 days.

Analysts like Kenvue less than other "consumer staples" companies. The consensus rating score for Kenvue is 2.00 while the average consensus rating score for "consumer staples" companies is 2.22. Learn more on how KVUE compares to other companies.


MarketBeat monitors more than a dozen sources for Kenvue analyst ratings, with the most recent rating issued on 9/11/2026.
From Our Partners